KRYS
Price
$136.94
Change
+$4.32 (+3.26%)
Updated
Jun 6 closing price
Capitalization
3.84B
64 days until earnings call
XERS
Price
$4.58
Change
+$0.12 (+2.69%)
Updated
Jun 6 closing price
Capitalization
714.29M
59 days until earnings call
Interact to see
Advertisement

KRYS vs XERS

Header iconKRYS vs XERS Comparison
Open Charts KRYS vs XERSBanner chart's image
Krystal Biotech
Price$136.94
Change+$4.32 (+3.26%)
Volume$265.91K
Capitalization3.84B
Xeris Biopharma Holdings
Price$4.58
Change+$0.12 (+2.69%)
Volume$1.82M
Capitalization714.29M
KRYS vs XERS Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. XERS commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a StrongBuy and XERS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (KRYS: $123.36 vs. XERS: $4.78)
Brand notoriety: KRYS and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 77% vs. XERS: 50%
Market capitalization -- KRYS: $3.84B vs. XERS: $714.29M
KRYS [@Biotechnology] is valued at $3.84B. XERS’s [@Biotechnology] market capitalization is $714.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, both KRYS and XERS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while XERS’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 4 bearish.
  • XERS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than XERS.

Price Growth

KRYS (@Biotechnology) experienced а -2.62% price change this week, while XERS (@Biotechnology) price change was -2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($3.84B) has a higher market cap than XERS($714M). XERS YTD gains are higher at: 41.003 vs. KRYS (-21.256). KRYS has higher annual earnings (EBITDA): 110M vs. XERS (-13.99M). KRYS has more cash in the bank: 598M vs. XERS (71.6M). KRYS has less debt than XERS: KRYS (7.26M) vs XERS (271M). KRYS has higher revenues than XERS: KRYS (291M) vs XERS (203M).
KRYSXERSKRYS / XERS
Capitalization3.84B714M537%
EBITDA110M-13.99M-786%
Gain YTD-21.25641.003-52%
P/E Ratio31.83N/A-
Revenue291M203M143%
Total Cash598M71.6M835%
Total Debt7.26M271M3%
FUNDAMENTALS RATINGS
KRYS vs XERS: Fundamental Ratings
KRYS
XERS
OUTLOOK RATING
1..100
5372
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
4671
SMR RATING
1..100
67100
PRICE GROWTH RATING
1..100
9037
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KRYS's Valuation (69) in the Pharmaceuticals Major industry is in the same range as XERS (91). This means that KRYS’s stock grew similarly to XERS’s over the last 12 months.

KRYS's Profit vs Risk Rating (46) in the Pharmaceuticals Major industry is in the same range as XERS (71). This means that KRYS’s stock grew similarly to XERS’s over the last 12 months.

KRYS's SMR Rating (67) in the Pharmaceuticals Major industry is somewhat better than the same rating for XERS (100). This means that KRYS’s stock grew somewhat faster than XERS’s over the last 12 months.

XERS's Price Growth Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for KRYS (90). This means that XERS’s stock grew somewhat faster than KRYS’s over the last 12 months.

KRYS's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as XERS (100). This means that KRYS’s stock grew similarly to XERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSXERS
RSI
ODDS (%)
Bullish Trend 12 days ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
72%
Bearish Trend 12 days ago
80%
Momentum
ODDS (%)
Bearish Trend 12 days ago
75%
Bearish Trend 12 days ago
80%
MACD
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
74%
Bearish Trend 12 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
75%
Bullish Trend 12 days ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
Bullish Trend 24 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
76%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
84%
Aroon
ODDS (%)
Bearish Trend 12 days ago
79%
Bullish Trend 12 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-2.44%
ACLX - KRYS
56%
Loosely correlated
-1.29%
IDYA - KRYS
56%
Loosely correlated
+0.72%
CRNX - KRYS
55%
Loosely correlated
+1.39%
CGON - KRYS
54%
Loosely correlated
-0.94%
XNCR - KRYS
54%
Loosely correlated
-2.58%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-1.04%
TRDA - XERS
51%
Loosely correlated
+0.91%
XNCR - XERS
48%
Loosely correlated
-2.58%
KRYS - XERS
46%
Loosely correlated
-2.44%
CGON - XERS
45%
Loosely correlated
-0.94%
YMAB - XERS
45%
Loosely correlated
+4.76%
More